Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV-2 infected macaques.

MLA

Van Rompay, Koen K. A., et al. “Early Treatment with a Combination of Two Potent Neutralizing Antibodies Improves Clinical Outcomes and Reduces Virus Replication and Lung Inflammation in SARS-CoV-2 Infected Macaques.” PLoS Pathogens, vol. 17, no. 7, July 2021, p. e1009688. EBSCOhost, https://doi.org/10.1371/journal.ppat.1009688.

APA

Van Rompay, K. K. A., Olstad, K. J., Sammak, R. L., Dutra, J., Watanabe, J. K., Usachenko, J. L., Immareddy, R., Verma, A., Shaan Lakshmanappa, Y., Schmidt, B. A., Roh, J. W., Elizaldi, S. R., Allen, A. M., Muecksch, F., Lorenzi, J. C. C., Lockwood, S., Pollard, R. E., Yee, J. L., Nham, P. B., … Reader, J. R. (2021). Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV-2 infected macaques. PLoS Pathogens, 17(7), e1009688. https://doi.org/10.1371/journal.ppat.1009688

Chicago

Van Rompay, Koen K A, Katherine J Olstad, Rebecca L Sammak, Joseph Dutra, Jennifer K Watanabe, Jodie L Usachenko, Ramya Immareddy, et al. 2021. “Early Treatment with a Combination of Two Potent Neutralizing Antibodies Improves Clinical Outcomes and Reduces Virus Replication and Lung Inflammation in SARS-CoV-2 Infected Macaques.” PLoS Pathogens 17 (7): e1009688. doi:10.1371/journal.ppat.1009688.